|
1
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang K, Kievit FM, Jeon M, Silber JR,
Ellenbogen RG and Zhang M: Nanoparticle-mediated target delivery of
TRAIL as gene therapy for glioblastoma. Adv Healthc Mater.
4:2719–2726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Delgado-López PD and Corrales-García EM:
Survival in glioblastoma: A review on the treatment modalities.
Clin Transl Oncol. 18:1062–1071. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li C, Jing H, Ma G and Liang P: Allicin
induces apoptosis through activation of both intrinsic and
extrinsic pathways in glioma cells. Mol Med Rep. 17:5976–5981.
2018.PubMed/NCBI
|
|
5
|
Nikolov V, Stojanovic M, Kostic A,
Radisavljevic M, Simonovic N, Jelenkovic B and Berilazic L: Factors
affecting the survival of patients with glioblastoma multiforme. J
BUON. 23:173–178. 2018.PubMed/NCBI
|
|
6
|
Han Y: Analysis of the role of the Hippo
pathway in cancer. J Transl Med. 17:1162019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tamura R, Tanaka T, Miyake K, Yoshida K
and Sasaki H: Bevacizumab formalignant gliomas: Current
indications, mechanisms of action and resistance, and markers of
response. Brain Tumor Pathol. 34:62–77. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li C, Zheng H, Hou W, Bao H, Xiong J, Che
W, Gu Y, Sun H and Liang P: Long non-coding RNA linc00645 promotes
TGF-β-induced epithelial-mesenchymal transition by regulating
miR-205-3p-ZEB1 axis in glioma. Cell Death Dis. 10:7172019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maruyama R and Suzuki H: Long noncoding
RNA involvement in cancer. BMB Rep. 45:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Do H and Kim W: Roles of oncogenic long
non-coding RNAs in cancer development. Genomics Inform. 16:e182018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vital AL, Tabernero MD, Castrillo A,
Rebelo A, Tão H, Gomes F, Nieto AB, Resende Oliveira C, Lopes MC
and Orfao A: Gene expression profiles of human glioblastomas are
associated with both tumor cytogenetics and histopathology. Neuro
Oncol. 12:991–1003. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang K, Zhao Z, Yu J, Chen W, Xu Q and
Chen L: lncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate
cancer cell proliferation, migration, and invasion in
hepatocellular carcinoma. J Cell Biochem. 119:6045–6056. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Westermarck J and Kahari VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gao X, Zhao S, Yang X, Zang S and Yuan X:
Long non-coding RNA FLVCR1-AS1 contributes to the proliferation and
invasion of lung cancer by sponging miR-573 to upregulate the
expression of E2F transcription factor 3. Biochem Biophys Res
Commun. 505:931–938. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin H, Shangguan Z, Zhu M, Bao L, Zhang Q
and Pan S: lncRNA FLVCR1-AS1 silencing inhibits lung cancer cell
proliferation, migration, and invasion by inhibiting the activity
of the Wnt/β-catenin signaling pathway. J Cell Biochem.
120:10625–10632. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan H, Li H, Silva MA, Guan Y, Yang L, Zhu
L, Zhang Z, Li G and Ren C: lncRNA FLVCR1-AS1 mediates miR-513/YAP1
signaling to promote cell progression, migration, invasion and EMT
process in ovarian cancer. J Exp Clin Cancer Res. 38:3562019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li S, Zeng A, Hu Q, Yan W, Liu Y and You
Y: miR-423-5p contributes to a malignant phenotype and temozolomide
chemoresistance in glioblastomas. Neuro Oncol. 19:55–65. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang D, Liu Z, Zheng N, Wu H, Zhang Z and
Xu J: miR-30b-5p modulates glioma cell proliferation by direct
targeting MDTH. Saudi J Biol Sci. 25:947–952. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhu ED, Li N, Li BS, Li W, Zhang WJ, Mao
XH, Guo G, Zou QM and Xiao B: miR-30b, down-regulated in gastric
cancer, promotes apoptosis and suppresses tumor growth by targeting
plasminogen activator inhibitor-1. PLoS One. 9:e1060492014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robinson MD, Mccarthy DJ and Smyth GK:
EdgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate-A practical and powerful approach to
multiple testing. J R Stat Soc. 57:289–300. 1995.
|
|
26
|
Ye Z, Jin H and Qian Q: Argonaute 2: A
novel rising star in cancer research. J Cancer. 6:877–882. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han L, Zhang K, Shi Z, Zhang J, Zhu J, Zhu
S, Zhang A, Jia Z, Wang G, Yu S, et al: lncRNA profile of
glioblastoma reveals the potential role of lncRNAs in contributing
to glioblastoma pathogenesis. Int J Oncol. 40:2004–2012.
2012.PubMed/NCBI
|
|
28
|
Zhang XQ, Sun S, Lam KF, Kiang KM, Pu JK,
Ho AS, Lui WM, Fung CF, Wong TS and leung GK: A long non-coding RNA
signature in glioblastoma multiforme predicts survival. Neurobiol
Dis. 58:123–131. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhi F, Wang Q, Xue L, Shao N, Wang R, Deng
D, Wang S, Xia X and Yang Y: The use of three long non-coding RNAs
as potential prognostic indicators of astrocytoma. PLoS One.
10:e01352422015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Sun S, Pu JK, Tsang AC, Lee D,
Man VO, Lui WM, Wong ST and Leung GK: Long non-coding RNA
expression profiles predict clinical phenotypes in glioma. Neurobio
Dis. 48:1–8. 2012. View Article : Google Scholar
|
|
31
|
Hu Y, Deng C, Zhang H, Zhang J, Peng B and
Hu C: Long non-coding RNA XIST promotes cell growth and metastasis
through regulating miR-139-5p mediated Wnt/β-catenin signaling
pathway in bladder cancer. Oncotarget. 8:94554–94568. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li C, Wan L, Liu Z, Xu G, Wang S, Su Z,
Zhang Y, Zhang C, Liu X, Lei Z and Zhang HT: Long non-coding RNA
XIST promotes TGF-β-induced epithelial-mesenchymal transition by
regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
Cancer Lett. 418:185–195. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous RNA
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20:E57582019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao J, Li L, Han ZY, Wang ZX and Qin LX:
Long noncoding RNAs, emerging and versatile regulators of
tumor-induced angiogenesis. Am J Cancer Res. 9:1367–1381.
2019.PubMed/NCBI
|
|
35
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R
and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition
and metastasis of bladder cancer by miR-29b-3p as competing
endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu Q, Shan S, Li Y, Zhu D, Jin W and Ren
T: Long noncoding RNA SNHG1 promotes non-small cell lung cancer
progression by up-regulating MTDH via sponging miR-145-5p. FASEB J.
32:3957–3967. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Oliveto S, Mancino M, Manfrini N and Biffo
S: Role of microRNAs in translation regulation and cancer. World J
Biol Chem. 8:45–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumar B, Khaleghzadegan S, Mears B, Hatano
K, Kudrolli TA, Chowdhury WH, Yeater DB, Ewing CM, Luo J, Isaacs
WB, et al: Identification of miR-30b-3p and miR-30d-5p as direct
regulators of androgen receptor signaling in prostate cancer by
complementary functional microRNA library screening. Oncotarget.
7:72593–72607. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Guo G, Zhong Z, Sun L, Liao L, Wang
X, Cao Q and Chen H: Long non-coding RNA FLVCR1-AS1 sponges miR-155
to promote the tumorigenesis of gastric cancer by targeting c-Myc.
Am J Transl Res. 11:793–805. 2019.PubMed/NCBI
|
|
41
|
Bao W, Cao F, Ni S, Yang J, Li H, Su Z and
Zhao B: lncRNA FLVCR1-AS1 regulates cell proliferation, migration
and invasion by sponging miR-485-5p in human cholangiocarcinoma.
Oncol Lett. 18:2240–2247. 2019.PubMed/NCBI
|
|
42
|
Yan Z, Zhang W, Xiong Y, Wang Y and Li Z:
Long noncoding RNA FLVCR1-AS1 aggravates biological behaviors of
gliomacells via targeting miR-4731-5p/E2F2 axis. Biochem Biophys
Res Commun. 521:716–720. 2020. View Article : Google Scholar : PubMed/NCBI
|
